GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
GSK plc (NYSE:GSK) confirmed the sale of 385.3 million shares in Haleon plc (NYSE:HLN) for $1.58 billion.
葛蘭素史克集團（紐約證券交易所代碼：GSK）確認以15.8億美元的價格出售Haleon plc（紐約證券交易所代碼：HLN）的3.853億股股份。
The shares represented around 4.2% of the issued share capital of Haleon.
這些股票約佔Haleon已發行股本的4.2％。
Following the settlement of the placing, GSK will have fully exited its position and will no longer hold any ordinary shares in Haleon.
配售和解後，葛蘭素史克將完全退出其頭寸，將不再持有Haleon的任何普通股。
Following the demerger and premium listing of Haleon in July 2022, GSK initially retained a 12.94% stake in Haleon.
繼2022年7月哈雷昂分拆並溢價上市後，葛蘭素史克最初保留了哈雷昂12.94％的股份。
As a result of the disposals, GSK has sold 1.19 billion shares in Haleon for cumulative gross proceeds.
由於此次出售，葛蘭素史克已出售了Haleon的11.9億股股份，以獲得累計總收益。
In October, GSK raised $1.1 billion, or £885.6 million, by selling some of its shares in Haleon, reducing its stake in the consumer healthcare business to around 7.4%.
10月，葛蘭素史克通過出售其在Haleon的部分股份籌集了11億美元，合8.856億英鎊，將其在消費者醫療保健業務中的股份減少至7.4％左右。
In May, GSK sold 240 million shares of Haleon in a move that has raised 804 million pounds for the firm. The offloaded shares are equivalent to up to 2.5% of Haleon's issued share capital.
5月，葛蘭素史克出售了Haleon的2.4億股股票，此舉爲該公司籌集了8.04億英鎊。卸下的股份相當於Haleon已發行股本的2.5％。
In March, Pfizer Inc (NYSE:PFE) announced plans to reduce its stake in Haleon to approximately 24%.
3月，輝瑞公司（紐約證券交易所代碼：PFE）宣佈計劃將其在Haleon的股份減少至約24％。
Price Action: HLN shares are up 0.60% at $8.41 during the premarket session at last check Friday.
價格走勢：在週五最後一次盤前交易中，HLN股價上漲0.60％，至8.41美元。
Now Read: Insider Activity Spotlight: Martin Harris Acquires In Colgate-Palmolive Stock Options
立即閱讀：內幕活動聚焦：馬丁·哈里斯收購高露潔-棕欖股票期權
Image: Wikimedia
圖片：維基媒體